From: A multiplex platform for the identification of ovarian cancer biomarkers
Protein | Early versus healthy | |||
---|---|---|---|---|
AUC (95% CI) | Rank | Sensitivity at 95% specificity (95% CI) | Rank | |
CA.125 | 0.98 (0.94, 1) | 1 | 0.93 (0.81, 0.99) | 1 |
HE4 | 0.85 (0.74, 0.95) | 2 | 0.63 (0.44, 0.84) | 2 |
CXCL13 | 0.82 (0.68, 0.93) | 3 | 0.44 (0.19, 0.71) | 7 |
FADD | 0.79 (0.67, 0.9) | 4 | 0.41 (0.14, 0.69) | 10 |
hK11 | 0.78 (0.65, 0.88) | 5 | 0.49 (0.26, 0.71) | 4 |
MK | 0.76 (0.65, 0.87) | 6 | 0.53 (0.33, 0.72) | 3 |
MMP.1 | 0.76 (0.62, 0.88) | 7 | 0.19 (0.05, 0.49) | 35 |
TNFSF14 | 0.76 (0.63, 0.89) | 8 | 0.09 (0, 0.38) | 65 |
IL.6 | 0.75 (0.65, 0.85) | 9 | 0.47 (0.18, 0.68) | 5 |
PRSS8 | 0.75 (0.62, 0.88) | 10 | 0.37 (0.16, 0.59) | 13 |
HGF | 0.75 (0.6, 0.87) | 11 | 0.21 (0.01, 0.51) | 29 |
CD40.L | 0.75 (0.6, 0.91) | 12 | 0.15 (0, 0.52) | 41 |
GDF.15 | 0.73 (0.58, 0.86) | 13 | 0.41 (0.22, 0.63) | 11 |
CD69 | 0.73 (0.59, 0.86) | 14 | 0.18 (0.03, 0.5) | 36 |
SCF | 0.72 (0.59, 0.85) | 15 | 0.39 (0.14, 0.63) | 12 |
LAP.TGF.beta.1 | 0.72 (0.57, 0.86) | 16 | 0.14 (0.02, 0.44) | 44 |
U.PAR | 0.72 (0.55, 0.86) | 17 | 0.15 (0.02, 0.5) | 42 |
NTRK3 | 0.71 (0.55, 0.86) | 18 | 0.15 (0.02, 0.45) | 40 |
Ep.CAM | 0.71 (0.53, 0.87) | 19 | 0.24 (0.09, 0.51) | 21 |
TF | 0.7 (0.55, 0.85) | 20 | 0.19 (0.06, 0.44) | 34 |
LITAF | 0.7 (0.52, 0.86) | 21 | 0.03 (0, 0.39) | 81 |
CDH3 | 0.7 (0.56, 0.88) | 22 | 0.42 (0.22, 0.67) | 8 |
EGFR | 0.7 (0.54, 0.85) | 23 | 0.08 (0.01, 0.37) | 66 |
VEGF.A | 0.69 (0.53, 0.83) | 24 | 0.21 (0.05, 0.5) | 28 |
TGF.alpha | 0.69 (0.53, 0.84) | 25 | 0.09 (0.01, 0.36) | 62 |